The Department of Cardiothoracic Surgery

The Department of Cardiothoracic Surgery is a recognized leader in heart, lung and esophagus surgery. Our experience with complex cardiothoracic issues and knowledge of the latest advances have helped to establish Weill Cornell Medicine|NewYork-Presbyterian as a major referral center for cardiovascular and thoracic patients from around the world.

Cardiac Surgery

The Division of Cardiac Surgery provides expert care to patients who need:

  • Coronary artery bypass surgery
  • Valve repair/replacement
  • Surgery for adult congenital heart disease
  • Minimally Invasive Heart Surgery
  • Ventricular Assist Devices (VADs)
Learn More
Cardiac Surgery team
Thoracic Surgery team

Thoracic Surgery

The Division of Thoracic Surgery offers the most advanced surgical care for:

  • Lung and esophageal cancers
  • Emphysema
  • Hyperhidrosis
  • Hiatal hernia
  • Pericardial & Pleural Effusions
  • Thoracentesis
Learn More

Cardiac Surgery

Adult & Pediatric

Thoracic Surgery

Lung & Esophagus

US World News 2016 Ranking

The Weill Cornell Medicine's Department of Cardiothoracic Surgery is proud to partner with NewYork-Presbyterian, ranked #6 in the nation and #1 in NYC by US News and World Report.

Clinical Trials

The Cardiothoracic Surgery Department conducts a robust clinical trials program to evaluate the effectiveness of new treatments and medications that have the potential to improve the management of patients with heart, lung, and esophageal disease. The outcomes of heart, lung, and esophageal operations can be improved with technical innovations.


"The Evolution of Minimally Invasive Esophagectomy"

November 7, 2016
8:00AM - 9:00AM Uris Auditorium
James D. Luketich, M.D.
Henry T. Bahnson Professor of Surgery
Chairman, Department of Cardiothoracic Surgery
Chief, Division of Thoracic and Foregut Surgery
University of Pittsburgh Medical Center"

Dr. Jeffrey Port and Dr. Sloane Guy are joining a panel of experts discussing the future of robotic innovations at the 92Y this October 27, 2016.
To sign up for this FREE Panel Event,
click here.

"Copper Depletion Therapy Keeps High-Risk Triple-Negative Breast Cancer at Bay"

Featured in Breast Cancer: Second Chances & New Advances, click here

Original Article, click here